This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zeiher, A. M. Articles by Just, H. Search for Related Content PubMed PubMed Citation Articles by Zeiher, A. M. Articles by Just, H.

Circulation, Vol 83, 1519-1525, Copyright © 1991 by American Heart Association

ARTICLES

Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease

AM Zeiher, V Schachinger, SH Weitzel, H Wollschlager and H Just
Department of Cardiology, University of Freiburg, FRG.

BACKGROUND. Experimental studies have demonstrated that intracoronary platelet aggregation and thrombus formation may induce marked vasoconstriction of epicardial arteries with endothelial injury. METHODS AND RESULTS. To examine the effects of intracoronary thrombus formation on coronary vasomotor tone of human epicardial arteries in vivo, we studied 15 patients who developed intracoronary thrombi adherent to the guide wire during balloon dilatation. Epicardial artery luminal area was evaluated by quantitative coronary angiography proximal and distal to the site of intracoronary thrombus formation and in a reference vessel before and after thrombus formation as well as after intracoronary injection of 0.2-0.3 mg nitroglycerin. All artery segments distal to the site of thrombus formation showed vasoconstriction with a luminal area reduction of -27.4 +/- 17.1% (p less than 0.001), whereas proximal vessel segments and reference vessels not manipulated during percutaneous transluminal coronary angioplasty did not demonstrate any significant luminal area changes during thrombus formation. Angiographic measurements after advancing the guide wire with the adherent thrombus (performed in six of the 15 patients) revealed in all patients that vasoconstriction did develop at a new site distal to the thrombus persistence of the initial vasoconstriction now residing proximal to the thrombus. Thus, there was a sequential association between thrombus formation and subsequent distal vasoconstriction. Intracoronary injection of nitroglycerin abolished the thrombus-induced vasoconstriction. No significant luminal area changes were observed in 20 patients without angiographic evidence of intracoronary thrombus formation. CONCLUSIONS. Intracoronary thrombus formation during percutaneous transluminal coronary angioplasty causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease. Although caution must be advised in the extrapolation of this phenomenon, which was observed in a manipulated artery during coronary angioplasty, the vasoconstrictor response to intracoronary thrombus formation in vivo may play an important role in the dynamic mechanisms of acute coronary heart disease syndromes.

This article has been cited by other articles:

				V. Schachinger and A. M. Zeiher Atherogenesis--recent insights into basic mechanisms and their clinical impact Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2055 - 2064. [Full Text] [PDF]

				Y.-T. Shen, R. T. Wiedmann, J. J. Lynch Jr, and R. J. Gould Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Preserves Coronary Flow Reserve During Progressive Coronary Arteriostenosis in Swine Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2309 - 2315. [Abstract] [Full Text] [PDF]

				H. Eguchi, H. Ikeda, T. Murohara, H. Yasukawa, N. Haramaki, S. Sakisaka, and T. Imaizumi Endothelial Injuries of Coronary Arteries Distal to Thrombotic Sites : Role of Adhesive Interaction Between Endothelial P-Selectin and Leukocyte Sialyl LewisX Circ. Res., March 19, 1999; 84(5): 525 - 535. [Abstract] [Full Text] [PDF]

				C. Depre, X. Havaux, J. Renkin, J. L. J. Vanoverschelde, and W. Wijns Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque Cardiovasc Res, February 1, 1999; 41(2): 465 - 472. [Abstract] [Full Text] [PDF]

				J. Frielingsdorf, P. Kaufmann, T. Suter, R. Hug, and O. M. Hess Percutaneous Transluminal Coronary Angioplasty Reverses Vasoconstriction of Stenotic Coronary Arteries in Hypertensive Patients Circulation, September 22, 1998; 98(12): 1192 - 1197. [Abstract] [Full Text] [PDF]

				J. Frielingsdorf, C. Seiler, P. Kaufmann, G. Vassalli, T. Suter, and O. M. Hess Normalization of Abnormal Coronary Vasomotion by Calcium Antagonists in Patients With Hypertension Circulation, April 1, 1996; 93(7): 1380 - 1387. [Abstract] [Full Text]

				V. Schachinger and A. M. Zeiher Quantitative Assessment of Coronary Vasoreactivity in Humans In Vivo : Importance of Baseline Vasomotor Tone in Atherosclerosis Circulation, October 15, 1995; 92(8): 2087 - 2094. [Abstract] [Full Text]

				A. M. Zeiher, V. Schachinger, and J. Minners Long-term Cigarette Smoking Impairs Endothelium-Dependent Coronary Arterial Vasodilator Function Circulation, September 1, 1995; 92(5): 1094 - 1100. [Abstract] [Full Text]

				E. Falk, P. K. Shah, and V. Fuster Coronary Plaque Disruption Circulation, August 1, 1995; 92(3): 657 - 671. [Full Text]

				A. M. Zeiher, H. Goebel, V. Schachinger, and C. Ihling Tissue Endothelin-1 Immunoreactivity in the Active Coronary Atherosclerotic Plaque : A Clue to the Mechanism of Increased Vasoreactivity of the Culprit Lesion in Unstable Angina Circulation, February 15, 1995; 91(4): 941 - 947. [Abstract] [Full Text]